Two classifications for bladder cancer grade are widely used; the World Health Organization (WHO) 1973 and the WHO 2004. We evaluated inter-observer variability of both classifications and investigated which histologic criteria cause this variability. We found that reproducibility of both classifications is poor, as well as scoring of the individual histologic criteria. This suggests that descriptions of these criteria for grade are not specific enough. Background: Histologic grade is an important prognosticator in patients with non–muscle-invasive bladder cancer (NMIBC). Currently, 2 classifications for grade are widely used; the World Health Organization (WHO) 1973 and the WHO 2004. We compare inter-observer variability of both classifica...
Objectives: This study assessed the diagnostic agreement and intra- and inter-observer reproducibili...
Background: The European Association of Urology (EAU) prognostic factor risk groups for non–muscle-i...
BACKGROUND: The European Association of Urology (EAU) prognostic factor risk groups for non-muscle-i...
BACKGROUND: Grading of noninvasive papillary urinary bladder carcinoma (PUC) is routinely performed ...
Background: A new grading system for bladder cancer (BCa) was adopted in 2004 to reduce observer var...
Background: Predicting the recurrence and progression of Non-muscle-invasive bladder cancer(NMIBC) i...
Objectives To compare the prognostic value of the World Health Organization (WHO) 1973 and 2004 clas...
Background: European treatment guidelines for pTa and pT1 urinary bladder urothelial carcinoma depen...
Predicting the recurrence and progression of Non-muscle-invasive bladder cancer(NMIBC) is critical f...
BACKGROUND: In the current European Association of Urology (EAU) non-muscle-invasive bladder cancer ...
Objectives: The Royal College of Pathologists minimum dataset recommends the concurrent use of both ...
Aims: To compare the 1973 WHO and the 2004/2016 WHO grading systems in patients with urothelial carc...
BACKGROUND: European treatment guidelines of TaT1 urinary bladder urothelial carcinomas depend highl...
Background: European treatment guidelines of TaT1 urinary bladder urothelial carcinomas depend highl...
European treatment guidelines of TaT1 urinary bladder urothelial carcinomas depend highly on stage a...
Objectives: This study assessed the diagnostic agreement and intra- and inter-observer reproducibili...
Background: The European Association of Urology (EAU) prognostic factor risk groups for non–muscle-i...
BACKGROUND: The European Association of Urology (EAU) prognostic factor risk groups for non-muscle-i...
BACKGROUND: Grading of noninvasive papillary urinary bladder carcinoma (PUC) is routinely performed ...
Background: A new grading system for bladder cancer (BCa) was adopted in 2004 to reduce observer var...
Background: Predicting the recurrence and progression of Non-muscle-invasive bladder cancer(NMIBC) i...
Objectives To compare the prognostic value of the World Health Organization (WHO) 1973 and 2004 clas...
Background: European treatment guidelines for pTa and pT1 urinary bladder urothelial carcinoma depen...
Predicting the recurrence and progression of Non-muscle-invasive bladder cancer(NMIBC) is critical f...
BACKGROUND: In the current European Association of Urology (EAU) non-muscle-invasive bladder cancer ...
Objectives: The Royal College of Pathologists minimum dataset recommends the concurrent use of both ...
Aims: To compare the 1973 WHO and the 2004/2016 WHO grading systems in patients with urothelial carc...
BACKGROUND: European treatment guidelines of TaT1 urinary bladder urothelial carcinomas depend highl...
Background: European treatment guidelines of TaT1 urinary bladder urothelial carcinomas depend highl...
European treatment guidelines of TaT1 urinary bladder urothelial carcinomas depend highly on stage a...
Objectives: This study assessed the diagnostic agreement and intra- and inter-observer reproducibili...
Background: The European Association of Urology (EAU) prognostic factor risk groups for non–muscle-i...
BACKGROUND: The European Association of Urology (EAU) prognostic factor risk groups for non-muscle-i...